Our Technology

Engineering platforms for next-generation drug discovery and biomedical innovation

VascuBio develops integrated technology platforms for 3D cell culture, high-throughput drug screening, vascularized tissue engineering, and precision diagnostics.

By combining microfluidics, biofabrication, and biomaterials, we create human-relevant systems that help researchers study disease, evaluate therapeutics, and develop next-generation biomedical tools.

Platform 01

3D Cell Culture, Biofabrication & Perfusion Bioreactors

Our biofabrication platform enables advanced 3D cell culture and controlled perfusion environments for engineered tissues and organoid-based models. These systems are designed to support more predictive drug screening workflows, from early-stage research to scalable high-throughput applications.

High-resolution microfabrication and 3D printing of microfluidic structures
Perfusion bioreactors enabling long-term culture of engineered tissues
Controlled microfluidic environments for biological experimentation
Modular systems designed for scalable research and screening applications

Platform 02

Vascularized Tissue& Organoid Platforms

VascuBio develops vascularized tissue and organoid systems designed to better replicate human physiology in vitro. By integrating perfusable vascular networks into engineered tissues, our platform enables more realistic biological models for studying disease and evaluating therapeutics. These technologies aim to bridge the gap between conventional cell culture and human biology, improving the predictive power of preclinical testing. These technologies are being developed to bridge the gap between conventional cell culture and human biology, with a focus on building more predictive platforms for high-throughput drug screening.

Engineering perfusable vascular networks within tissue constructs
Multi-cellular tissue models for disease modeling and drug screening
Biomaterial scaffolds with tunable mechanical and biochemical properties
Integration with perfusion systems for long-term tissue maturation

Platform 03

Microfluidic Diagnostic Systems

In addition to tissue engineering platforms, VascuBio develops microfluidic diagnostic technologies designed to make advanced testing more accessible. Our diagnostic platforms leverage microfluidics, biosensing technologies, and advanced data analysis to enable rapid and scalable detection of disease biomarkers.

Microfluidic sample processing and assay automation
Minimal sample volume requirements
Rapid biomarker detection platforms
Designed for point-of-care and decentralized testing environments

Applications

Our platforms support a wide range of applications across biotechnology, pharmaceutical research, and healthcare.

High-Throughput Drug Screening

3D cell culture, tissue, and organoid-based platforms designed to improve therapeutic testing and preclinical decision-making.

Disease Modeling

Advanced in vitro models that replicate human physiology to study disease mechanisms.

Regenerative Medicine

Engineered tissue platforms supporting research in tissue repair and regeneration.

Clinical Diagnostics

Microfluidic diagnostic technologies designed for early disease detection and accessible testing.

Biomedical Research

Tools enabling researchers to build more physiologically relevant experimental systems.

3D Cell Culture

Advanced microfluidic and perfusion-enabled systems for building more physiologically relevant in vitro models.